Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
The EPA implements solutions for forever chemical cleanup
In a remarkable step toward environmental protection, the Environmental Protection Agency (EPA) took decisive steps last Friday to address the dangers of two forever ...
Read MoreWhat is “weaponized kindness” and how can you protect your relationship from it?
In the delicate dance of love, kindness often serves as the melody that orchestrates harmony between couples. From modest gestures like morning coffees to ...
Read MoreHow to cook your veggies to boost their anti-inflammatory powers
Every year the cold winter weather doesn’t only put frost on the grass, it also brings an increased chance of getting sick. And that’s ...
Read MoreNewly discovered “nano-chameleon” fits atop your fingertip
In the northern regions of Madagascar, scientists have discovered the smallest reptile species known to humankind: the Brookesia nana, also known as the nano-chameleon. ...
Read More
